StockMatchby Pulse Deck

Latest evidence-based view

BBC · SELL

BBC: managing your position takes priority over adding more. 1 month -16.85% · 3 months -17.60% · 1 year +58.54%.

BUYOriginal source alertSELLEvidence-reviewed stance240Alert timeframe

BBC: managing your position takes priority over adding more.

1 month -16.85% · 3 months -17.60% · 1 year +58.54%. Taken together, the verified indicators provide stronger negative evidence.

A short-term rebound is possible, but the current balance of evidence favors reducing exposure.

If you hold a position, reduce it gradually. Delay new purchases until the three-month trend recovers.

Market evidence

44.6601Reference price
-16.851-month return
-17.63-month return
58.541-year return
59.452-week range position
2026-10-05T13:30:00+00:00Market data as of

Instrument profile

Virtus Biotech Clinical Trials ETF

DescriptionVirtus Biotech Clinical Trials ETFSecurity TypefundSecurity SubtypeetfSectorMiscellaneousIndustryInvestment Trusts/Mutual FundsBeta 1Y1.2Expense Ratio Percent0.65Nav44.548